where to from here ?, page-16

With CEPH still selling $3.70 above the bid from VRX the market is expecting a higher price.With the record date of April 8 having passed VRX should be able to get an up to date list of holders and calculate their chances of success.The CEO of VRX intends to look elsewhere if he can't get support from CEPH shareholders to install his nominees on the Board of CEPH.This would be the best outcome for CXS shareholders.Hopefully the future will be a lot clearer in a few weeks.VRX has a small but growing interest in Australia.In 2009 sales in Australia were about 5% of total sales.From the 2009 Annual Report.

"We also expect to see strong results from our Australian business in 2010, now that we have brought the operation up to scale. With the
acquisitions we completed in 2009, we now have a strong portfolio of local brands such as Dr. LeWinn,Hissyfi, Dermaveen ,UV Triplegard and others, that will supplement our successful and reputable Nyal franchise. Overall, our Australian business is
expected to increase 60% to 80% in 2010 as we focus our efforts on our newly acquired brands"